Artificial Pancreas Devices System Market Size, Share, Analysis and Forecasts, 2017 To 2021

About Artificial Pancreas Devices System

Artificial organs are human-made bioartificial devices, which are implanted or integrated into individuals to replace or support natural organs. These include artificial heart, kidney, pancreas, and cochlear implants. Biocompatible materials such as polymers (polyurethane, polysulfone, and porous polypropylene), biologics, ceramics, and metals are used to develop artificial organs. These organs are incorporated with different technologies like sensors, biomaterials, and innovative delivery systems. Artificial organs perform the function of the natural organ and help the patient to live a quality life. In few cases, artificial organs are capable of eliminating the need for organ transplantation altogether.

Technavios analysts forecast the global artificial pancreas devices system market to grow at a CAGR of 7.40% during the period 2016-2020.

Browse full report with TOC @ https://marketreportscenter.com/reports/482230/global-artificial-pancreas-devices-system-market-2016-2020

Global Artificial Pancreas Devices System Market 2016-2020

Report recognizes the following companies as the key players in the global artificial pancreas devices system market: Medtronic, Johnson & Johnson, Insulet, Tandem Diabetes Care, and Roche.

Other Prominent Vendors in the market are: Beta Bionics, Bigfoot Biomedical, Cellnovo, Dexcom, Dose Safety, DreaMed Diabetes, Inreda Diabetic, and Type Zero Technologies.

Commenting on the report, an analyst from Reports team said: One trend in the market is increasing focus on closed loop systems. The increasing demand for APDS has driven the vendors to undertake extensive clinical trials toward product improvement, which are expected to have a positive impact on the market growth. The vendors such as Medtronic, Tandem Diabetes Care, Johnson & Johnson, and Insulet are currently focusing on the development of closed loop APDS, which is expected to propel the market growth owing to its potential advantages compared with existing APDS. The existing open loop APDS are low glucose suspend devices with semi-automation. As these systems are not integrated with advanced algorithms, the required user intervention is at a moderate level. On the contrary, closed-loop APDS are externally worn medical devices, which would enable individuals with type 1 diabetes to regulate blood glucose levels in a fully automated way with zero intervention required from the user.”

According to the report, one driver in the market is increasing initiatives of research organizations fostering innovation in the market. The inspiring initiatives of research organizations such as JDRF enable the development of innovative products in the market. JDRF launched Artificial Pancreas Project in 2006 to foster the development of an artificial pancreas to help individuals with diabetes. Subsequently, JDRF collaborated with Medtronic in 2014 to develop a novel redundant sensor system, which is designed to boost the accuracy and reliability of APDS. The research also focused on the development of orthogonally redundant sensor system, which integrates an electrochemical sensor along with an optical sensor to provide accurate glucose values. Earlier, in June 2013, JDRF collaborated with BD for a three-year time period to develop a single optimized device that will handle multiple functions and avoid the need and complexities of dwelling catheters. Recently, the researchers at Harvard University started a program to identify and develop an effective treatment for type 1 diabetes. Subsequently, National Institutes of Health awarded $12.5 million to Harvard University in 2016 to undertake the field testing of two artificial pancreas algorithms. Such initiatives lead to the development of novel products as well as upgradation of existing systems. 

Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/482230

Further, the report states that one challenge in the market is lack of smart control algorithms affecting the adoption rate of existing APDS. Though there are important developments in sensor and pump technology, the APDS is associated with the delays and inaccuracies in glucose sensing and insulin delivery. Such type of issues occurs when there is a disturbance in the routine system (such as uptake of meal), which triggers a rapid glucose rise that is significantly faster than the time required for insulin absorption and action. Thus, the vendors should focus on designing an APDS with smart sensors that consider a relatively slow response, giving time for the delays to fade before the next control action. In particular, to avoid hypoglycemia after a meal, the vendors has to design a moderately aggressive controller. This has driven the vendors to research on new control design, model predictive control (MPC) algorithm, which is based on a prediction of glucose dynamics using a model of the individual's metabolic system. According to clinical studies, this design may be better for mitigation of time delays due to subcutaneous glucose sensing and insulin infusion. However, such smart algorithms have limited clinical evidence, and it may take few more years to develop an ideal algorithm.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Covered in this report 

The report covers the present scenario and the growth prospects of the global artificial pancreas devices system market for 2016-2020. To calculate the market size, the report considers the revenue generated from sales of the different products.

The market is divided into the following segments based on geography: 

Americas

APAC

EMEA

Technavio's report, Global Artificial Pancreas Devices System Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

To Get Discount On The Report @ https://marketreportscenter.com/request-discount/482230

US Nurse Call System Market Trends, Growth, Price, Demand and Forecasts To 2021

About Nurse Call System Market in the US

The NCS helps a caregiver and a patient to effectively communicate with each other and enhance patient care. In the US, individuals undergoing treatment in specialized healthcare facilities such as in SNFs, ALFs, and ACFs need constant attention and care. Hence, to provide 24/7 care to them, there is a need for a dedicated line of communication between patients and caregivers; NCS are used for this purpose. 

Technavios analysts forecast the nurse call system market in the US to grow at a CAGR of 14.18% during the period 2016-2020.

Browse full report with TOC @ https://marketreportscenter.com/reports/482225/nurse-call-system-market-in-the-us-2016-2020

Nurse Call System Market in the US 2016-2020

Report recognizes the following companies as the key players in the nurse call system market in the US: Ascom, Jeron Electronic Systems, Rauland-Borg, and TekTone.

Other Prominent Vendors in the market are: Austco, Awarepoint, Azentro, Critical Alert Systems, Comm-Tronics, Cornell Communications, Elpas, Intercall Systems, Live Sentinel, Mircom, NiQ Health, Philips, Sonitor Technologies, Systems Technologies, Tyco SimplexGrinnell, WestCall, and York Electronic Systems.

Commenting on the report, an analyst from Reports team said: The latest trend gaining momentum in the market is improvement in healthcare communication. With the introduction of integrated healthcare communications technology, administrative heads or nursing directors can access NCS data from their offices or remote computers. Using this technology, supervisors can assign staff to patients, send text messages to the staff, review report data, and view patient call activity. Other departments not associated with NCS also benefit as these systems provide remote access to NCS information.”

According to the report, one of the major drivers for this market is advances in technology. In recent years, technological innovations have resulted in the development of new and improved NCS. Initially, only analog systems were available in the market. However, with advances in technology, analog systems have been replaced by digital equipment. Also, wired systems are being replaced by wireless systems. Vendors have undertaken R&D to redesign and upgrade their NCS and enhance efficiency.

Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/482225

Further, the report states that one of the major factors hindering the growth of this market is high cost of NCS installation and maintenance. The cost of NCS installation depends on the type of rooms in healthcare facilities. The cost is also dependent on whether wired or wireless technology is used in these facilities. High cost and maintenance of these systems can hinder the adoption, which can affect market growth adversely.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Covered in this report 

The report covers the present scenario and the growth prospects of the nurse call system market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of NCS, including nurse call components such as pagers and smartphones.

Technavio's report, Nurse Call System Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

To Get Discount On The Report @ https://marketreportscenter.com/request-discount/482225

Pompe Disease Treatment Market Trends, Growth, Price, Demand and Forecasts To 2021

About Pompe Disease Treatment

Lysosomal storage diseases (LSDs) are a group of progressive, autosomal recessive, and hereditary disorders characterized by the accumulation of specific substrates and variable age of onset and clinical symptoms. Pompe disease, a type of LSD, is caused by mutations in the GAA gene. These mutations inhibit the mechanism of action (MOA) of GAA; it is an enzyme responsible for catabolizing glycogen, resulting in accumulation of glycogen to toxic levels in the lysosomes of the cells. The buildup of glycogen in certain tissues and organs, especially in the muscles, hinders the normal functions of the organs. It can be further divided as adult-onset and infantile-onset Pompe diseases. As the disease is an autosomal recessive hereditary disorder, both parents are carriers and pass one copy of the mutated gene to their offspring. It affects both women and men across all ethnicities and races and has a varied age of onset of symptoms. Till date, researchers have identified over 300 genetic mutation types that lead to disease manifestation. Though there is no known cure for Pompe disease, enzyme replacement therapy (ERT) and diet therapy have been effective in reducing its clinical manifestations.

Technavios analysts forecast the global Pompe disease treatment market to grow at a CAGR of 11.85% during the period 2016-2020.

Browse full report with TOC @ https://marketreportscenter.com/reports/482223/global-pompe-disease-treatment-market-2016-2020

Global Pompe Disease Market 2016-2020

Report recognizes the following companies as the key players in the global Pompe disease treatment market: Amicus Therapeutics, Audentes Therapeutics, and Sanofi-Genzyme

Other Prominent Vendors in the market are: EpiVax, Oxyrane, Sangamo BioSciences, and Valerion Therapeutics

Commenting on the report, an analyst from Reports team said: Usually, a substantial amount of revenue is spent on spreading awareness of the drug and disease, after its launch. Also, the post-marketing response for the drug involves approaching all the diseased individuals. Therefore, the limited population of Pompe disease patients worldwide results in reduced expenditure on, advertising, marketing, and awareness programs.”

According to the report, the US FDA's OOPD aims to develop and evaluate biologics, drugs, and devices that effectively cure and diagnose rare diseases, and extends benefits to underlying companies. It also grants orphan status to biologics and drugs proven to be effective and safe in treating rare diseases. The Orphan Products Clinical Trials Grants Program funds the clinical research tests to check the efficacy and safety of drugs, medical devices, and biologics.

Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/482223

Further, the report states that various events and fundraising programs are being organized by government and non-government organizations to raise awareness and educate people about the Pompe disease and its diagnosis and treatment options resulting in social and economic benefits and improvement in patients' quality of life. Organizations such as the United Pompe Foundation, International Pompe Association, Canadian Association of Pompe, Acid Maltase Deficiency Association, and National Organization for Rare Disorders (NORD) are involved in promoting various events online and offline to spread awareness.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Covered in this report 

The report covers the present scenario and the growth prospects of the global Pompe disease treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of the drugs available in the market and the drug candidates that are in various phases of development for the treatment of Pompe disease.

The market is divided into the following segments based on geography: 

Americas

APAC

EMEA

Technavio's report, Global Pompe Disease Treatment Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

To Get Discount On The Report @ https://marketreportscenter.com/request-discount/482223

HPV Testing Market Size, Share, Analysis and Forecasts, 2017 To 2021

About HPV Testing

According to Centers for Disease Control and Prevention (CDC), human papillomavirus (HPV) refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other types of HPV cause non-genital warts that are not sexually transmitted. Though most HPV infections are harmless and heal on their own, certain high-risk types of genital HPV can be persistent and cause cervical, penile, anal, vaginal, and oropharyngeal cancers. Many individuals, especially women, undergo regular HPV tests as a preventive measure. HPV tests help to detect the viral genetic material in a cell sample taken from the cervix.

Technavios analysts forecast the global HPV testing market to grow at a CAGR of 16.17% during the period 2016-2020.

Browse full report with TOC @ https://marketreportscenter.com/reports/482222/global-hpv-testing-market-2016-2020

Global HPV Testing Market 2016-2020

Report recognizes the following companies as the key players in the global HPV testing market: Abbott Laboratories, BD, Roche Diagnostics, and Qiagen

Other Prominent Vendors in the market are: Arbor Vita, Breakspear Medical, Cepheid, DAAN Gene, DiaCarta, Delphi Bioscience, Fujirebio Diagnostics, Genera Biosystems, IncellDx, OralDNA Labs, Seegene, SoloPap, and Trovagene

Commenting on the report, an analyst from Reports team said: HPV and Pap tests help to detect cervical cancer in women. The Pap test identifies changes in cervical cells caused by HPV infection. The HPV test is used to check for HPV genotypes in sample cells. A physician may advise a patient to undergo both HPV and Pap tests for the screening of cervical cancer. The American Cancer Society, the US Preventive Services Task Force, the American Society for Clinical Pathology, and the American Society for Colposcopy and Cervical Pathology have provided guidelines for the testing of cervical cancer in women in the US. These guidelines state that women aged 30-65 years should undergo Pap and HPV co-testing every five years or undergo Pap test every three years.”

According to the report, vendors in the market have developed innovative home-based products that provide quick and accurate test results. This can help to reduce the cost burden on patients and keep cervical cancer at bay. The adoption of HPV home testing kits is growing developing countries owing to increasing awareness, which is striving the market growth.

Request A Sample copy of This Report @ https://marketreportscenter.com/reports/482222/global-hpv-testing-market-2016-2020

Further, the report states that HPV screening test is adopted by many healthcare centers as it can predict the risk of cervical cancer. The result can be positive or negative. If positive, then the individual has to undergo Pap test or colposcopy. Through Pap test, the physician can understand the presence of abnormal or precancerous cells in the cervix. HPV test is a better predictor of low cervical cancer risk; however Pap test can be more efficient in those cases. Based on sensitivity and specificity, Pap test is adopted more than HPV testing.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Covered in this report

The report covers the present scenario and the growth prospects of the global HPV testing market for 2016-2020. To calculate the market size, the report considers only the HPV test products used for genital cancer screening such as cervical cancer.

The market is divided into the following segments based on geography: 

Americas

APAC

EMEA

Technavio's report, Global HPV Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

To Get Discount On The Report @ https://marketreportscenter.com/request-discount/482222

Laparotomy Sponges Market Trends, Growth, Price, Demand and Forecasts To 2021

About Laparotomy Sponges

A laparotomy sponge is a highly absorbent and tightly-woven cotton gauze with radiopaque tapes or a detectable X-ray string on the sides. Laparotomy sponges are of two types: sterile and non-sterile. The sponge is placed under the edge of an incision to protect soft tissues and exposed organs during surgery. It absorbs blood and exudates from the incised region at target site. There has been a surge in life-threatening conditions such as cardiovascular diseases, infectious diseases, and neurological disorders across the world that has led to a soaring need for medication and often surgeries, both critical and normal.

Technavios analysts forecast the global laparotomy sponges market to grow at a CAGR of 7.94% during the period 2016-2020.

Browse full report with TOC @ https://marketreportscenter.com/reports/482219/global-laparotomy-sponges-market-2016-2020

Global Laparotomy Sponges Market 2016-2020

Report recognizes the following companies as the key players in the global laparotomy sponges market: Derma Sciences, Medtronic, Owens & Minor, and Medline.

Other Prominent Vendors in the market are: A Plus International, Across Medical Disposables, Actimed, AllCare, B. Braun Melsungen, Cardinal Health, ClearCount Medical Solutions, Cremer, DeRoyal, DUKAL, Fomed Industries, Frank Healthcare, Guangda textile, Haldor, Henan Godsen Medical Devices, Jiangsu Yongtai Datang Medical Material, Komal Health Care, Matoshri Surgical, Medicaux Healthcare, Medicom, Ningbo Evergrand Healthcare, Premier Enterprises, RF Surgical Systems, SurgicCount Medical, Suzhou Hengxiang Medical Dressing, Suzhou Sunmed, V&Q Manufacturing, VWR, and Wuhan Jianeryou Health Products.

Commenting on the report, an analyst from Reports team said: The latest trend gaining momentum in the market is manufacturing of laparotomy sponges by textile companies. The production of medical products is no longer limited to healthcare companies alone. Rapid growth in the healthcare sector has provided opportunities to other sector companies as well to develop healthcare products. For instance, electronics companies are manufacturing healthcare IT products. Similarly, a few local textile vendors are also producing laparotomy sponges and other medical dressing products, such as bandages and operating room towels.

According to the report, one of the major drivers for this market is growing number of abdominal laparotomy procedures. The growing number of laparotomy procedures is expected to drive the global laparotomy sponges market. The increasing number of laparotomy procedures is due to increased prevalence of intestinal diseases. Further, the growing number of bariatric surgeries are expected to drive the demand in the market, owing to the rise in obesity cases.

Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/482219

Further, the report states that one of the major factors hindering the growth of this market is complications involved in the usage of laparotomy sponges. Despite several efforts by hospitals and vendors, retained laparotomy sponges continue to be the number one reported complication after surgery. Retained surgical sponges and other surgical foreign bodies unintentionally left at surgical sites are rare medical errors that have the potential to cause harm to the individual.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Covered in this report 

The report covers the present scenario and the growth prospects of the global laparotomy sponges market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various laparotomy sponges to key end-users such as hospitals and ambulatory surgical centers.

The market is divided into the following segments based on geography: 

Americas

APAC

EMEA

Technavio's report, Global Laparotomy Sponges Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

To Get Discount On The Report @ https://marketreportscenter.com/request-discount/482219